Since ID1 is a well-established oncoprotein that promotes cancer cell survival and proliferation (Perk et al., 2005), we hypothesize that the increase of ID1 may confer adaptive resistance to HIF1α-targeted inhibition. The gene discussed is HIF1A; the disease is cancer.